Quality of life in patients with allergic and immunologic skin diseases: in the eye of the beholder.
Allergic contact dermatitis
Allergy
Atopic dermatitis
Cutaneous mastocytosis
Hereditary angioedema
Quality of life
Skin
Urticaria
Journal
Clinical and molecular allergy : CMA
ISSN: 1476-7961
Titre abrégé: Clin Mol Allergy
Pays: England
ID NLM: 101152195
Informations de publication
Date de publication:
20 Dec 2021
20 Dec 2021
Historique:
received:
04
10
2021
accepted:
15
11
2021
entrez:
21
12
2021
pubmed:
22
12
2021
medline:
22
12
2021
Statut:
epublish
Résumé
Allergic and immunologic skin diseases negatively impact the quality of life (QoL) of affected patients with detrimental consequences. Nonetheless, in everyday clinical practice the evaluation of QoL is often overlooked. Considering the increasing prevalence of atopic dermatitis, allergic contact dermatitis, hereditary angioedema, cutaneous mastocytosis, and urticaria, it is essential to determine the effects of allergic and immunologic skin diseases on QoL. A joint meeting (GET TOGETHER 2021) of the Italian Society of Allergology, Asthma and Clinical Immunology (SIAAIC) and the Italian Society of Allergological, Occupational and Environmental Dermatology (SIDAPA) aimed to summarize the features of the main QoL tools used in these diseases and to describe the extent of QoL impairment as well as the impact of treatments on QoL, particularly biologic therapies. The assessment of QoL in patients with allergic and immunologic skin diseases relies on generic, organ-specific and disease-specific questionnaires. While generic and organ-specific questionnaires allow comparison between different diseases, disease-specific questionnaires are designed and validated for specific cohorts: the QoL Index for Atopic Dermatitis (QoLIAD) and the Childhood Atopic Dermatitis Impact Scale (CADIS) in atopic dermatitis, the ACD-11 in allergic contact dermatitis, the Angioedema QoL Questionnaire (AE-QoL) and the Hereditary Angioedema QoL questionnaire (HAE-QoL) in hereditary angioedema, the Mastocytosis QoL Questionnaires (MCQoL e MQLQ) in cutaneous mastocytosis, and the Chronic Urticaria QoL questionnaire (CU-Q2oL) in urticaria. Among the many factors that variably contribute to QoL impairment, pruritus can represent the leading cause of patient discomfort. Biologic therapies significantly ameliorate QoL in atopic dermatitis, hereditary angioedema, mastocytosis and chronic urticaria. In general, adequate management strategies are essential for improving QoL in patients with allergic and immunologic skin diseases.
Identifiants
pubmed: 34930291
doi: 10.1186/s12948-021-00165-6
pii: 10.1186/s12948-021-00165-6
pmc: PMC8690422
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
26Informations de copyright
© 2021. The Author(s).
Références
J Allergy Clin Immunol. 2014 May;133(5):1365-72, 1372.e1-6
pubmed: 24522090
J Invest Dermatol. 2015 Jan;135(1):67-75
pubmed: 25046337
Contact Dermatitis. 2019 Aug;81(2):89-96
pubmed: 30802323
J Investig Allergol Clin Immunol. 2020 Aug 26;:0
pubmed: 32856595
Contact Dermatitis. 2011 Sep;65(3):138-45
pubmed: 21722138
Br J Dermatol. 2000 Aug;143(2):365-72
pubmed: 10951147
Br J Dermatol. 1997 Feb;136(2):197-201
pubmed: 9068731
Acta Derm Venereol. 2015 Feb;95(2):206-10
pubmed: 24923641
J Allergy Clin Immunol. 2011 Sep;128(3):567-73.e1
pubmed: 21762974
J Allergy Clin Immunol. 2016 Jun;137(6):1742-1750.e4
pubmed: 27040372
Contact Dermatitis. 2014 Feb;70(2):69-80
pubmed: 24600708
J Am Acad Dermatol. 1997 Jul;37(1):41-50
pubmed: 9216522
J Am Acad Dermatol. 2003 Jan;48(1):128-30
pubmed: 12522383
J Dermatol. 2017 Apr;44(4):375-385
pubmed: 27862227
Immunol Lett. 2018 Nov;203:29-39
pubmed: 30218740
J Invest Dermatol. 2007 Dec;127(12):2726-39
pubmed: 17989733
Actas Dermosifiliogr. 2017 May;108(4):346-353
pubmed: 28219634
Allergy. 2020 Feb;75(2):423-432
pubmed: 31494963
Allergy. 2016 Nov;71(11):1585-1593
pubmed: 27089859
J Allergy Clin Immunol Pract. 2021 Aug;9(8):3166-3175.e2
pubmed: 33965596
J Invest Dermatol. 2017 Jul;137(7):1454-1460
pubmed: 28259682
PLoS One. 2008 May 28;3(5):e2266
pubmed: 18509466
Nat Rev Dis Primers. 2021 May 27;7(1):38
pubmed: 34045488
J Eur Acad Dermatol Venereol. 2021 Apr;35(4):958-964
pubmed: 33332697
Am J Contact Dermat. 1997 Dec;8(4):215-21
pubmed: 9417366
Syst Rev. 2021 May 7;10(1):141
pubmed: 33962662
J Am Acad Dermatol. 2006 Oct;55(4):705-9
pubmed: 17010756
J Am Acad Dermatol. 2008 Jul;59(1):145-7
pubmed: 18468722
Br J Dermatol. 2010 Dec;163(6):1166-8
pubmed: 21137114
JAMA. 2018 Nov 27;320(20):2108-2121
pubmed: 30480729
Clin Mol Allergy. 2020 May 6;18:8
pubmed: 32390768
Allergy. 2017 Dec;72(12):2005-2016
pubmed: 28543019
Immunol Allergy Clin North Am. 2017 Aug;37(3):597-616
pubmed: 28687112
Intern Med. 2018 Nov 1;57(21):3065-3066
pubmed: 30210137
Clin Transl Allergy. 2017 Oct 6;7:36
pubmed: 29043014
Orphanet J Rare Dis. 2021 Feb 15;16(1):86
pubmed: 33588897
J Clin Nurs. 2019 Apr;28(7-8):1114-1124
pubmed: 30230078
Ann Allergy Asthma Immunol. 2014 Oct;113(4):460-6.e2
pubmed: 24980392
Allergy Asthma Clin Immunol. 2015 Jul 21;11(1):21
pubmed: 26195984
Ann Allergy Asthma Immunol. 2015 Apr;114(4):281-288.e7
pubmed: 25707325
Am J Clin Dermatol. 2020 Feb;21(1):119-131
pubmed: 31823222
Clin Exp Allergy. 2020 Jun;50(6):654-661
pubmed: 32107810
J Allergy Clin Immunol Pract. 2016 May-Jun;4(3):464-473.e4
pubmed: 26969268
J Allergy Clin Immunol Pract. 2019 May - Jun;7(5):1659-1661.e1
pubmed: 30496828
Dermatitis. 2004 Sep;15(3):117-24
pubmed: 15724345
Allergy. 2014 May;69(5):602-16
pubmed: 24673465
J Eur Acad Dermatol Venereol. 2018 Mar;32(3):e112-e113
pubmed: 28924988
Allergy. 2021 Sep 18;:
pubmed: 34536239
Allergol Int. 2017 Apr;66(2):317-325
pubmed: 27599913
Ann Allergy Asthma Immunol. 2020 Jan;124(1):2-12
pubmed: 31446134
Clin Exp Dermatol. 1994 May;19(3):210-6
pubmed: 8033378
Med Care. 1993 Mar;31(3):247-63
pubmed: 8450681
Br J Dermatol. 2014 Aug;171(2):304-12
pubmed: 24397866
J Allergy Clin Immunol. 2019 Jan;143(1):1-11
pubmed: 30612663
Mol Psychiatry. 2016 Nov;21(11):1511-1516
pubmed: 26809839
J Allergy Clin Immunol Pract. 2018 Jul - Aug;6(4):1185-1190.e1
pubmed: 29128337
J Allergy Clin Immunol Pract. 2021 Mar;9(3):1053-1065
pubmed: 33685604
J Allergy Clin Immunol Pract. 2014 Jan-Feb;2(1):70-6
pubmed: 24565772
Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S383-412
pubmed: 22588759
Contact Dermatitis. 2020 Sep;83(3):179-181
pubmed: 32347968
Br J Dermatol. 2020 May;182(5):1120-1135
pubmed: 31407311
Allergy. 2011 Jul;66(7):840-4
pubmed: 21385184
Pediatr Allergy Immunol. 2007 May;18(3):245-9
pubmed: 17433002
Int J Immunopathol Pharmacol. 2006 Jan-Mar;19(1):237-40
pubmed: 16569363
Contact Dermatitis. 2009 Sep;61(3):145-51
pubmed: 19780772
Br J Dermatol. 2019 Jul;181(1):80-87
pubmed: 30791102
Br J Dermatol. 2016 Dec;175(6):1153-1165
pubmed: 27237730
Pediatr Dermatol. 2005 May-Jun;22(3):192-9
pubmed: 15916563
J Invest Dermatol. 2012 Nov;132(11):2534-43
pubmed: 22696057
Allergy. 2018 Mar;73(3):576-584
pubmed: 29058822
Allergy. 2010 Apr;65(4):516-28
pubmed: 19860762
N Engl J Med. 2019 Oct 3;381(14):1321-1332
pubmed: 31577874
Dermatitis. 2016 Nov/Dec;27(6):362-371
pubmed: 27775978
Dermatol Ther. 2020 Nov;33(6):e13946
pubmed: 32618048
J Biol Chem. 2014 Aug 22;289(34):23596-608
pubmed: 24970892
Dermatology. 2019;235(3):167-174
pubmed: 30928986
J Am Acad Dermatol. 2014 Aug;71(2):327-49
pubmed: 24813298
J Am Acad Dermatol. 2017 May;76(5):1000-1004
pubmed: 28411766
Br J Dermatol. 2003 Sep;149(3):452-6
pubmed: 14510974
J Microbiol Immunol Infect. 2007 Jun;40(3):260-4
pubmed: 17639168
J Eur Acad Dermatol Venereol. 2017 Oct;31(10):1715-1721
pubmed: 28573683
Br J Clin Pharmacol. 2014 Nov;78(5):970-80
pubmed: 24833043
Clin Rev Allergy Immunol. 2021 Oct;61(2):114-127
pubmed: 32607924
G Ital Dermatol Venereol. 2019 Jun;154(3):227-253
pubmed: 30717577
Allergy. 2013 Jul;68(7):949-52
pubmed: 23734572
N Engl J Med. 2020 Mar 19;382(12):1136-1148
pubmed: 32187470
J Eur Acad Dermatol Venereol. 2017 Jun;31(6):1056-1063
pubmed: 27911016
N Engl J Med. 2016 Dec 15;375(24):2335-2348
pubmed: 27690741
J Allergy Clin Immunol. 2020 Aug;146(2):356-366.e4
pubmed: 32437738
Clin Dermatol. 2020 Mar - Apr;38(2):176-192
pubmed: 32513398
Dermatitis. 2019 Sep/Oct;30(5):300-305
pubmed: 31524758
Allergy. 2016 Jun;71(6):869-77
pubmed: 26797792
Allergy. 2018 Jul;73(7):1393-1414
pubmed: 29336054
J Am Acad Dermatol. 2018 Oct;79(4):617-633
pubmed: 30241624
Am Fam Physician. 2010 Aug 1;82(3):249-55
pubmed: 20672788
Allergy. 2018 Aug;73(8):1575-1596
pubmed: 29318628
Ann Allergy Asthma Immunol. 2020 Apr;124(4):373-378.e2
pubmed: 31923542
Clin Rev Allergy Immunol. 2020 Aug;59(1):38-45
pubmed: 32418171
Ann Allergy Asthma Immunol. 2016 Oct;117(4):370-377.e1
pubmed: 27424128
Allergy. 2021 Jan;76(1):59-70
pubmed: 32767573
Br J Dermatol. 2008 Nov;159(5):997-1035
pubmed: 18795920
J Am Acad Dermatol. 2019 Jan;80(1):280-281.e1
pubmed: 30092326
Dermatol Res Pract. 2019 Mar 3;2019:3797536
pubmed: 30941167
Dermatitis. 2020 May/Jun;31(3):209-214
pubmed: 32049717
Contact Dermatitis. 2001 Jul;45(1):17-20
pubmed: 11422262
J Dtsch Dermatol Ges. 2011 Jul;9(7):525-32
pubmed: 21992665
Allergy. 2013 Sep;68(9):1185-92
pubmed: 23919330
JAMA Dermatol. 2019 Jan 1;155(1):29-38
pubmed: 30427977
Allergy. 2018 Jan;73(1):230-238
pubmed: 28662309
J Allergy Clin Immunol Pract. 2018 Mar - Apr;6(2):586-599
pubmed: 28916431
Br J Dermatol. 2002 Apr;146(4):627-30
pubmed: 11966694
Br J Dermatol. 2004 Feb;150(2):274-83
pubmed: 14996098
Acta Derm Venereol. 2018 Jul 11;98(7):641-647
pubmed: 29648675
Allergy. 2016 Aug;71(8):1203-9
pubmed: 27038109
Eur Rev Med Pharmacol Sci. 2018 Feb;22(3):820-828
pubmed: 29461615
Am J Contact Dermat. 1998 Sep;9(3):149-54
pubmed: 9744907
Dermatitis. 2016 Jul-Aug;27(4):176-85
pubmed: 27427819
Dermatitis. 2010 Mar-Apr;21(2):84-90
pubmed: 20233546
J Investig Allergol Clin Immunol. 2013;23(4):287-8
pubmed: 23964563
Clin Rev Allergy Immunol. 2019 Feb;56(1):99-109
pubmed: 30293200
Contact Dermatitis. 2003 May;48(5):244-7
pubmed: 12868963
Front Med (Lausanne). 2017 Dec 04;4:212
pubmed: 29255709
Allergy. 2018 Jul;73(7):1489-1496
pubmed: 29405310
N Engl J Med. 2017 Feb 23;376(8):717-728
pubmed: 28225674
Allergol Int. 2021 Oct;70(4):471-479
pubmed: 34023225
Allergy Asthma Proc. 2014 Sep-Oct;35(5):371-6
pubmed: 25295804
J Dermatol Sci. 2019 May;94(2):266-275
pubmed: 31109652
Int J Occup Med Environ Health. 2008;21(4):309-17
pubmed: 19158071
Ann Allergy Asthma Immunol. 2014 Feb;112(2):170-4
pubmed: 24468258
J Eur Acad Dermatol Venereol. 2020 Sep;34(9):1924-1931
pubmed: 32662100
N Engl J Med. 2013 Mar 7;368(10):924-35
pubmed: 23432142
Health Qual Life Outcomes. 2012 Jul 20;10:82
pubmed: 22817696
J Am Acad Dermatol. 2003 Dec;49(6):1037-48
pubmed: 14639382
J Rheumatol Suppl. 2011 Nov;88:2-6
pubmed: 22045972
Blood. 2017 Mar 16;129(11):1420-1427
pubmed: 28031180
BMC Med Res Methodol. 2021 Apr 26;21(1):86
pubmed: 33902436
Acta Dermatovenerol Alp Pannonica Adriat. 2009 Jun;18(2):53-8, 60, 62
pubmed: 19588058
J Allergy Clin Immunol Pract. 2018 Sep - Oct;6(5):1733-1741.e3
pubmed: 29391286
Health Qual Life Outcomes. 2019 Oct 26;17(1):160
pubmed: 31655579
Med Clin North Am. 2020 Jan;104(1):61-76
pubmed: 31757238
J Eur Acad Dermatol Venereol. 2015 Jun;29 Suppl 3:38-44
pubmed: 26053294
J Allergy Clin Immunol Pract. 2019 May - Jun;7(5):1679-1683.e7
pubmed: 30550806
Dermatitis. 2018 Sep/Oct;29(5):282-284
pubmed: 30179979
Allergy. 2021 Apr;76(4):1188-1198
pubmed: 33258114
Expert Opin Biol Ther. 2018 Apr;18(4):425-448
pubmed: 29431518
Int J Dermatol. 2002 Mar;41(3):151-8
pubmed: 12010340
J Allergy (Cairo). 2011;2011:964509
pubmed: 21603173
Contact Dermatitis. 2014 Feb;70(2):81-9
pubmed: 24450824
J Drugs Dermatol. 2020 Oct 1;19(10):978-983
pubmed: 33026762
Front Med (Lausanne). 2018 Mar 12;4:245
pubmed: 29594115
Allergy. 2011 Mar;66(3):317-30
pubmed: 21083565
Allergy. 2012 Oct;67(10):1289-98
pubmed: 22913638
Immunol Allergy Clin North Am. 2018 Aug;38(3):505-525
pubmed: 30007467
J Dermatol Sci. 2014 Jan;73(1):57-62
pubmed: 24060603
Ann Allergy Asthma Immunol. 2015 May;114(5):418-9.e1
pubmed: 25747788